生物科技公司Erasca股价在盘后交易时段下跌3.5%。公司于同日宣布，计划通过公开发行筹集高达5亿美元的资金，发行标的为普通股。此项融资提案旨在为公司运营及管线开发提供资金支持。市场对股权稀释的担忧，或是导致股价在消息公布后应声走低的主要原因。
生物科技公司Erasca股价在盘后交易时段下跌3.5%。公司于同日宣布，计划通过公开发行筹集高达5亿美元的资金，发行标的为普通股。此项融资提案旨在为公司运营及管线开发提供资金支持。市场对股权稀释的担忧，或是导致股价在消息公布后应声走低的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.